We now could also demonstrate that neither midostaurin nor avapritinib had an effect on the multimutated KIT D816V negative compartment, which may lead to KIT independent resistance and progression, e.g., secondary KIT D816 negative acute myeloid leukemia [43]. Here, KIT is linked to acute myeloid leukemia.